Onward Medical N.V.
ISIN: NL0015000HT4 | Ticker: ONWD | LEI: 9845007A2CC4C8BFSB80
Country: Netherlands
ONWARD is headquartered in Eindhoven, the Netherlands. It maintains a Science and Engineering Center in Lausanne, Switzerland, and has a growing U.S. presence in Boston, Massachusetts.
Our work builds on decades of research and translational science by giants in this important and emerging field. Our ARC Therapy is designed to deliver targeted, programmed stimulation of the spinal cord to restore movement and other functions in people with spinal cord injury
2014
Served areaWorldwide
HeadquartersHigh Tech Campus 32, 5656 Eindhoven – Netherlands
| Line item in (eur) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Assets | N/A | 104,796,000.00 | 76,593,000.00 |
| Noncurrent Assets | N/A | 12,409,000.00 | 12,417,000.00 |
| Property Plant And Equipment | N/A | 190,000.00 | 415,000.00 |
| Deferred Tax Assets | N/A | 0.00 | 163,000.00 |
| Current Assets | N/A | 92,387,000.00 | 64,176,000.00 |
| Trade And Other Current Receivables Due From Related Parties | N/A | 60,000.00 | 251,000.00 |
| Current Value Added Tax Receivables | N/A | 339,000.00 | 709,000.00 |
| Cash and cash equivalents | 6,382,000.00 | 89,443,000.00 | 41,760,000.00 |
| Shortterm Deposits Not Classified As Cash Equivalents | N/A | 0.00 | 20,000,000.00 |
| Current Prepayments And Other Current Assets | N/A | 2,546,000.00 | 1,456,000.00 |
| Equity And Liabilities | N/A | 104,796,000.00 | 76,593,000.00 |
| Issued Capital | N/A | 3,622,000.00 | 3,622,000.00 |
| Retained Earnings | N/A | -75,974,000.00 | -108,319,000.00 |
| Share Premium | N/A | 155,249,000.00 | 155,249,000.00 |
| Other Reserves | N/A | -214,000.00 | 2,079,000.00 |
| Equity Attributable To Owners Of Parent | -32,095,000.00 | 82,683,000.00 | 52,631,000.00 |
| Noncurrent Liabilities | N/A | 16,571,000.00 | 15,741,000.00 |
| Deferred Tax Liabilities | N/A | 1,991,000.00 | 670,000.00 |
| Noncurrent Recognised Liabilities Defined Benefit Plan | N/A | 1,388,000.00 | 1,121,000.00 |
| Longterm Borrowings | N/A | 11,451,000.00 | 12,656,000.00 |
| Current Liabilities | N/A | 5,542,000.00 | 8,221,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 952,000.00 | 1,909,000.00 |
| Other Current Payables | N/A | 4,034,000.00 | 5,666,000.00 |
| Current Tax Liabilities Current | N/A | 83,000.00 | 219,000.00 |
| Line item in (eur) | 01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|
| Profit Loss From Operating Activities | -28,532,000.00 | -32,028,000.00 |
| Finance Income | 0.00 | 62,000.00 |
| Finance Costs | 5,713,000.00 | 1,572,000.00 |
| Profit Loss Before Tax | -34,245,000.00 | -33,538,000.00 |
| Income Tax Expense Continuing Operations | 69,000.00 | -766,000.00 |
| Profit (loss) | -34,314,000.00 | -32,772,000.00 |
| Profit Loss Attributable To Owners Of Parent | -34,314,000.00 | -32,772,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 0.00 | 0.00 |
| Line item in (eur) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Profit (loss) | N/A | -34,314,000.00 | -32,772,000.00 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | N/A | -43,000.00 | 0.00 |
| Adjustments For Sharebased Payments | N/A | 8,564,000.00 | 1,691,000.00 |
| Other Adjustments For Noncash Items | N/A | -2,000.00 | 106,000.00 |
| Interest Paid Classified As Operating Activities | N/A | 146,000.00 | 229,000.00 |
| Interest Received Classified As Operating Activities | N/A | 0.00 | 15,000.00 |
| Cash Flows From Used In Operating Activities | N/A | -19,874,000.00 | -26,685,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 91,000.00 | 386,000.00 |
| Purchase Of Intangible Assets Classified As Investing Activities | N/A | 2,233,000.00 | 31,000.00 |
| Cash Flows From Used In Investing Activities | N/A | -2,324,000.00 | -20,417,000.00 |
| Proceeds From Issuing Shares | N/A | 80,106,000.00 | 0.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 30,000,000.00 | 0.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 144,000.00 | 557,000.00 |
| Cash Flows From Used In Financing Activities | N/A | 105,361,000.00 | -557,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 83,162,000.00 | -47,659,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -100,000.00 | -24,000.00 |
| Cash and cash equivalents | 6,382,000.00 | 89,443,000.00 | 41,760,000.00 |
Please note that some sums might not add up.
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 19.01.23 | G.R. Courtine | Non-Executive member | Other | EUR 0.00 |
| 03.01.23 | D.L. Marver | Non-Executive member | Other | EUR 0.00 |
| 23.12.22 | F.A. Colen | Non-Executive member | Other | EUR 0.00 |
| 18.11.22 | D.L. Marver | Non-Executive member | Other | EUR 0.00 |
| 29.09.22 | V.E. Riefberg | Non-Executive member | Other | EUR 0.00 |
| 15.12.21 | J.K. Ohrstrom | Non-Executive member | Other | EUR 0.00 |
| 22.10.21 | D.L. Marver | Non-Executive member | Other | EUR 0.00 |
NL0015000HT4
LEI9845007A2CC4C8BFSB80
SectorHealth Care Equipment & Services
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.